Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ayr Wellness Inc C.AYR.A

Alternate Symbol(s):  AYRWF

AYR Wellness Inc. is a vertically integrated multi-state cannabis operator in the United States. The Company operates simultaneously as a retailer with more than 90 licensed dispensaries and a house of cannabis consumer packed goods (CPG) brands. It is a cultivator, manufacturer and retailer of cannabis products and branded CPG, and is engaged in the manufacture, possession, use, sale, or distribution of cannabis and/or holds licenses in the adult-use and/or medicinal cannabis marketplace in the States of Massachusetts, Nevada, Pennsylvania, Florida, New Jersey, Ohio, Illinois, and Connecticut. The Company’s portfolio of CPG brands includes Kynd, Origyn Extracts, Levia, STiX Preroll Co., Secret Orchard, and Entourage, among others. It owns and operates a chain of cannabis retail stores under various brand names. The Company distributes and markets its products to Company-owned retail stores and to third-party licensed retail cannabis stores throughout its operating footprint.


CSE:AYR.A - Post by User

Post by AwareInvestoron Mar 10, 2021 2:07pm
124 Views
Post# 32764212

Ayr Wellness: Fourth Quarter Consensus Estimates

Ayr Wellness: Fourth Quarter Consensus Estimates
Ayr Wellness is set to report their fourth quarter and year end financials before market open on March 11th. Analysts have a consensus C$54.60 12-month price target on the company, via a total of four analysts, with one analyst having a strong buy rating and the other three have buy ratings. The street high comes from Beacon Securities with a C$76 price target, and the lowest target comes from PI Financial with a C$60 price target.
<< Previous
Bullboard Posts
Next >>